Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 165

Sort by

Sort Order Select

Journal Articles

Atypical hemolytic uremic Syndrome Triggered by malignancy and drug exposure: A systematic review and meta-analysis

Moazzam Shahzad, Farooq Ashraf, Sayyam Razzaq, Hafiz Muhammad Hannan Javed, Muhammad Shaheer Mannan, Muhammaf Fareed Khalid, Fatima Sial, Atif Butt, Anas Al-sadi, Ibrahim Khamees, Sarmad Zaman Warraich, Michael Jaglal, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 2689.

https://doi.org/10.1182/blood-2025-2689

Published: 2025

Journal Articles

Sociodemographic and patient-related determinants of outcomes after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Moazzam Shahzad, Aqeeb Ur Rehman, Shah Rukh, Muhammad Kashif Amin, Amir Kasaeian, Hammad Shafi, Forat Lutfi, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 7684.

https://doi.org/10.1182/blood-2025-7684

Published: 2025

Journal Articles

Incidence, patterns, and outcomes of adenovirus infections in patients following allogeneic hematopoietic cell transplantation

Areeba Ismail, Amna Bint I Munir, Fatima Imran, Muhammad Shahzou Shah, Zunaira Amjad, Muhammad Zeeshan, Hammad Shafi, Muhammad Kashif Amin, Joseph McGuirk, Moazzam Shahzad, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 7733.

https://doi.org/10.1182/blood-2025-7733

Published: 2025

Journal Articles

Efficacy, quality of life, and safety of non-clotting factor prophylaxis in Hemophilia A and b: A meta-analysis across inhibitor status

Abdul basit Khan, Rehan Ishaque, Sibgha Fawad Memon, Zauha fawad Memon, Matia Fawad Memon, Fawad Talat, Aswanth Reddy, Madhuri yalamanchili, Muhammad Kashif Amin, Muhammad Umair Mushtaq, Moazzam Shahzad, Supratik Rayamajhi

Blood (2025) 146 (Supplement 1): 6628.

https://doi.org/10.1182/blood-2025-6628

Published: 2025

Journal Articles

Outcomes and associated factors after melphalan 140 mg/m² autologous hematopoietic cell transplantation for multiple myeloma in patients over 70 years of age

Aqeeb Ur Rehman, Moazzam Shahzad, Shah Rukh, Zeeshan Sattar, Muhammad Kashif Amin, Jeries Kort, Al-Ola Abdallah, Leyla Shune, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 5985.

https://doi.org/10.1182/blood-2025-5985

Published: 2025

Journal Articles

Impact of donor age on transplant outcomes in unrelated allogeneic hematopoietic stem cell transplantation using post-transplant cyclophosphamide-based gvhd prophylaxis

Muhammad Kashif Amin, Moazzam Shahzad, Matthew McGuirk, Asma Zakir, Al-Ola Abdallah, Nausheen Ahmed, Sunil Abhyankar, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 173.

https://doi.org/10.1182/blood-2025-173

Published: 2025

Journal Articles

Comparative safety and efficacy of bendamustine versus fludarabine/cyclophosphamide prior to chimeric antigen receptor- T cell therapy: A systematic review and meta-analysis

Muhammad Kashif Amin, Tehseen Raza, Hira Habib, Nabeeha Noor, Muhammad Usman, Fatima Imran, Rameen Fatima, Muhammad Zohaib Qasim, Hammad Shafi, Moazzam Shahzad, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 6320.

https://doi.org/10.1182/blood-2025-6320

Published: 2025

Journal Articles

Impact of early bacteremia on clinical outcomes following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based gvhd prophylaxis

Moazzam Shahzad, Shah Rukh, Aroog Khaliq, Aqeeb Ur Rehman, Amna Bint I Munir, Muhammad Kashif Amin, Amir Kasaeian, Anthony Sung, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 4200.

https://doi.org/10.1182/blood-2025-4200

Published: 2025

Journal Articles

Optimal dose and duration of venetoclax for induction therapy in acute myeloid leukemia and myelodysplastic syndrome: A systematic review and meta-analysis

Mamoon Ahmed, Farooq Ashraf, Anas Al-sadi, Muhammad Shaheer Mannan, Jehad Zeidalkilani, Hafsa Shahid, Aniqa Faraz, Maheen Zahid, Aman Ullah, Sohaib Irfan, Sarmad Zaman Warraich, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 2831.

https://doi.org/10.1182/blood-2025-2831

Published: 2025

Journal Articles

Thirty-day readmission in patients with brain cancer and venous thromboembolism: A nationwide analysis using the national readmissions database

Jawad Ahmed, Muhammad Umer Sohail, Muhammad Asjad Riaz, Jazza Jamil, Ahmad Khan, Saman Adnan, Muskan Kumari, Muhammad Umair Noor, Zain Ali Nadeem, Jay Kakadiya, Fnu Bhuvan

Blood (2025) 146 (Supplement 1): 7984.

https://doi.org/10.1182/blood-2025-7984

Published: 2025

Journal Articles

Outcomes of haploidentical hematopoietic stem cell transplantation in low- and middle-income countries: A systematic review and meta-analysis.

Moazzam Shahzad, Muhammad Kashif Amin, Rehan Ishaque, Mahad Zamir, Muhammad Junaid Azhar, Syed Aftab Haider Kamran, Muhammad Abdullah, Roma Bai, Ammara Saleem, Hammad Shafi, Raheel Iftikhar, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 7816.

https://doi.org/10.1182/blood-2025-7816

Published: 2025

Journal Articles

Single-arm meta-analysis of melflufen-based regimens in relapsed/refractory multiple myeloma: Efficacy and safety insights from clinical trials

Abdul basit Khan, Fawad Talat, Zauha fawad Memon, Rehan Ishaque, Sibgha Fawad Memon, Matia Fawad Memon, Hira Rehman, Hamza Janjua, Aswanth Reddy, Muhammad Umair Mushtaq, Muhammad Kashif Amin, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 7568.

https://doi.org/10.1182/blood-2025-7568

Published: 2025

Journal Articles

Outcomes with chimeric antigen receptor-t cell therapy in relapsed/refractory b-cell acute lymphoblastic leukemia: A systematic review and meta-analysis

Hafiz Muhammad Hannan Javed, Muhammad Kashif Amin, Hafsa Shahid, Sarmad Zaman Warraich, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 6875.

https://doi.org/10.1182/blood-2025-6875

Published: 2025

Journal Articles

Outcomes with ponatinib in patients with relapsed/refractory Philadelphia-chromosome positive acute lymphoblastic leukemia: A systematic review and meta-analysis

Hafiz Muhammad Hannan Javed, Muhammad Kashif Amin, Zeeshan Sattar, Mamoon Ahmed, Aman Ullah, Aminah Tayyab, Waleeh Ahmed Mir, Fatima Sial, Ruhma Sehar, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 6873.

https://doi.org/10.1182/blood-2025-6873

Published: 2025

Journal Articles

Outcomes with repeat CAR-t cell therapy: A systematic review and meta-analysis

Hafiz Muhammad Hannan Javed, Fatima Sial, Farooq Ashraf, Aman Ullah, Muhammad Umair Mushtaq, Moazzam Shahzad, Salman Khan

Blood (2025) 146 (Supplement 1): 7632.

https://doi.org/10.1182/blood-2025-7632

Published: 2025

Journal Articles

Outcomes with a fixed duration combination of bruton tyrosine kinase inhibitors and venetoclax in chronic lymphocytic leukemia: A systematic review and meta-analysis

Hafiz Muhammad Hannan Javed, Farooq Ashraf, Fatima Sial, Hafsa Shahid, Syed Muhammad Ali Najafi, Atif Butt, Muhammad Shaheer Mannan, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 7432.

https://doi.org/10.1182/blood-2025-7432

Published: 2025

Journal Articles

The durability of consolidative transplant in mediastinal gray zone lymphoma, a single institution retrospective

Neda Amirmokhtari, Jianzheng Wu, Marc Hoffmann, Aung Tun, Joseph Bennett, Nausheen Ahmed, Muhammad Umair Mushtaq, Shaun DeJarnette, Forat Lutfi

Blood (2025) 146 (Supplement 1): 7197.

https://doi.org/10.1182/blood-2025-7197

Published: 2025

Journal Articles

The role of high-dose vitamin c in management of hematological malignancies: Asystematic review and meta-analysis

Zeeshan Sattar, Muhammad Kashif Amin, Hafiz Muhammad Hannan Javed, Amir Kasaeian, Iman Menbary, Ruhma Sehar, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 8116.

https://doi.org/10.1182/blood-2025-8116

Published: 2025

Journal Articles

Comparative trends in mortality from acute lymphoblastic and Acute Myeloid Leukemia in the United States: A CDC wonder analysis (1999–2020)

Zauha fawad Memon, Sibgha Fawad Memon, Rehan Ishaque, Sarmad Masaud, Matia Fawad Memon, Amna Ikram, Shajadi Patan, Furqan Tarique Memon, Muhammad Kashif Amin, Joseph McGuirk, Moazzam Shahzad, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 4619.

https://doi.org/10.1182/blood-2025-4619

Published: 2025

Journal Articles

Outcomes with prophylactic anticoagulation in hemolytic anemias: A systematic review

Hafiz Muhammad Hannan Javed, Aminah Tayyab, Sarmad Zaman Warraich, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 6665.

https://doi.org/10.1182/blood-2025-6665

Published: 2025

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Atypical hemolytic uremic Syndrome Triggered by malignancy and drug exposure: A systematic review and meta-analysis

Sociodemographic and patient-related determinants of outcomes after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Incidence, patterns, and outcomes of adenovirus infections in patients following allogeneic hematopoietic cell transplantation

Efficacy, quality of life, and safety of non-clotting factor prophylaxis in Hemophilia A and b: A meta-analysis across inhibitor status

Outcomes and associated factors after melphalan 140 mg/m² autologous hematopoietic cell transplantation for multiple myeloma in patients over 70 years of age

Impact of donor age on transplant outcomes in unrelated allogeneic hematopoietic stem cell transplantation using post-transplant cyclophosphamide-based gvhd prophylaxis

Comparative safety and efficacy of bendamustine versus fludarabine/cyclophosphamide prior to chimeric antigen receptor- T cell therapy: A systematic review and meta-analysis

Impact of early bacteremia on clinical outcomes following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based gvhd prophylaxis

Optimal dose and duration of venetoclax for induction therapy in acute myeloid leukemia and myelodysplastic syndrome: A systematic review and meta-analysis

Thirty-day readmission in patients with brain cancer and venous thromboembolism: A nationwide analysis using the national readmissions database

Outcomes of haploidentical hematopoietic stem cell transplantation in low- and middle-income countries: A systematic review and meta-analysis.

Single-arm meta-analysis of melflufen-based regimens in relapsed/refractory multiple myeloma: Efficacy and safety insights from clinical trials

Outcomes with chimeric antigen receptor-t cell therapy in relapsed/refractory b-cell acute lymphoblastic leukemia: A systematic review and meta-analysis

Outcomes with ponatinib in patients with relapsed/refractory Philadelphia-chromosome positive acute lymphoblastic leukemia: A systematic review and meta-analysis

Outcomes with repeat CAR-t cell therapy: A systematic review and meta-analysis

Outcomes with a fixed duration combination of bruton tyrosine kinase inhibitors and venetoclax in chronic lymphocytic leukemia: A systematic review and meta-analysis

The durability of consolidative transplant in mediastinal gray zone lymphoma, a single institution retrospective

The role of high-dose vitamin c in management of hematological malignancies: Asystematic review and meta-analysis

Comparative trends in mortality from acute lymphoblastic and Acute Myeloid Leukemia in the United States: A CDC wonder analysis (1999–2020)

Outcomes with prophylactic anticoagulation in hemolytic anemias: A systematic review

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only